Amgen's US Biosimilar Launches Are Off To A Steady Start, With A Big Coverage Decision

 
• By Jessica Merrill

United HealthCare agreed to cover Mvasi and Kanjinti in a preferred position. Amgen VP-oncology sales & marketing Susan Logan talked to Scrip about the company's first US biosimilar launches.

Lake-geneva

More from New Products

More from Scrip